+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Alzheimer's Disease Drugs Market Research Reports

From
From
Alzheimer Disease Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Alzheimer Disease Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 111 Pages
  • China
From
Alzheimer Disease Drugs Companies in China - Product Thumbnail Image

Alzheimer Disease Drugs Companies in China

  • Report
  • November 2023
  • 74 Pages
  • China
From
Namenda - API Insight, 2022 - Product Thumbnail Image

Namenda - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Namenda- Drug Insight, 2019 - Product Thumbnail Image

Namenda- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
From
From
From
Loading Indicator

The Alzheimer's Disease Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs to treat Alzheimer's Disease. Alzheimer's Disease is a progressive neurological disorder that affects memory, thinking, and behavior. It is the most common form of dementia, and is estimated to affect over 5 million people in the United States alone. The Alzheimer's Disease Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include Eli Lilly, Pfizer, Novartis, Merck, and Johnson & Johnson. These companies are developing and marketing drugs to treat Alzheimer's Disease, such as cholinesterase inhibitors, memantine, and monoclonal antibodies. Additionally, many of these companies are researching and developing new treatments for Alzheimer's Disease, such as gene therapy and stem cell therapy. Show Less Read more